Tadmor, Tamar, Ohad Benjamini, Neta Goldschmidt, Natlia Kreiniz, Osnat Bairey, Reut Harel, Nadav Sarid, Tsofia Levi, Ofir Wolach, and Yair Herishanu. 2020. “Fixed-Duration Obinutuzumab-Ibrutinib-Venetoclax for Richter’s Transformation: Results from the Phase II GIVeRS Trial”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.300749.